• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于文献的方法用于多维疾病中基因特征的策展。

A literature-based approach for curating gene signatures in multifaceted diseases.

机构信息

Research Department, Sidra Medicine, Doha, Qatar.

出版信息

J Transl Med. 2020 Jul 10;18(1):279. doi: 10.1186/s12967-020-02408-7.

DOI:10.1186/s12967-020-02408-7
PMID:32650786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7350750/
Abstract

BACKGROUND AND AIMS

The task of identifying a representative and yet manageable target gene list for assessing the pathogenesis of complicated and multifaceted diseases is challenging. Using Inflammatory Bowel Disease (IBD) as an example, we conceived a bioinformatic approach to identify novel genes associated with the various disease subtypes, in combination with known clinical control genes.

METHODS

From the available literature, we used Acumenta Literature Lab (LitLab), network analyses, and LitLab Gene Retriever to assemble a gene pool that has a high likelihood of representing immunity-related subtype-specific signatures of IBD.

RESULTS

We generated six relevant gene lists and 21 intersections that contain genes with unique literature associations to Crohn's Disease (n = 60), Ulcerative Colitis (n = 17), and unclassified (n = 45) subtypes of IBD. From this gene pool, we then filtered and constructed, using network analysis, a final list of 142 genes that are the most representative of the disease and its subtypes.

CONCLUSIONS

In this paper, we present the bioinformatic construction of a gene panel that putatively contains subtype signatures of IBD, a multifactorial disease. These gene signatures will be tested as biomarkers to classify patients with IBD, which has been a clinically challenging task. Such approach to diagnose and monitor complicated disease pathogenesis is a stepping-stone towards personalized care.

摘要

背景与目的

确定具有代表性且易于管理的靶基因列表,以评估复杂和多方面疾病的发病机制是一项具有挑战性的任务。以炎症性肠病(IBD)为例,我们构思了一种生物信息学方法,以识别与各种疾病亚型相关的新基因,同时结合已知的临床对照基因。

方法

我们从现有文献中使用 Acumenta Literature Lab(LitLab)、网络分析和 LitLab Gene Retriever 来组合一个基因库,该基因库极有可能代表与 IBD 的免疫相关亚型特异性特征相关的基因。

结果

我们生成了六个相关的基因列表和 21 个交集,其中包含与克罗恩病(n=60)、溃疡性结肠炎(n=17)和未分类(n=45)IBD 亚型具有独特文献关联的基因。然后,我们从这个基因库中筛选并构建了一个使用网络分析的最终包含 142 个基因的列表,这些基因最能代表疾病及其亚型。

结论

在本文中,我们提出了一种生物信息学构建的基因面板,该面板可能包含 IBD 的亚型特征,这是一种多因素疾病。这些基因特征将作为分类 IBD 患者的生物标志物进行测试,这是一项具有临床挑战性的任务。这种诊断和监测复杂疾病发病机制的方法是迈向个性化护理的一步。

相似文献

1
A literature-based approach for curating gene signatures in multifaceted diseases.基于文献的方法用于多维疾病中基因特征的策展。
J Transl Med. 2020 Jul 10;18(1):279. doi: 10.1186/s12967-020-02408-7.
2
Bioinformatics analysis reveals transcriptome and microRNA signatures and drug repositioning targets for IBD and other autoimmune diseases.生物信息学分析揭示了 IBD 和其他自身免疫性疾病的转录组和 microRNA 特征以及药物重定位靶点。
Inflamm Bowel Dis. 2012 Dec;18(12):2315-33. doi: 10.1002/ibd.22958. Epub 2012 Apr 5.
3
Familial occurrence and inheritance studies in inflammatory bowel disease.炎症性肠病的家族发病情况及遗传研究。
Neth J Med. 1996 Feb;48(2):53-6. doi: 10.1016/0300-2977(95)00093-3.
4
Association of susceptibility locus for inflammatory bowel disease on chromosome 16 with both ulcerative colitis and Crohn's disease.16号染色体上炎症性肠病易感性位点与溃疡性结肠炎和克罗恩病的关联
Dig Dis Sci. 2001 Mar;46(3):632-6. doi: 10.1023/a:1005623904826.
5
Bioinformatic analysis of potential candidates for therapy of inflammatory bowel disease.炎症性肠病治疗潜在候选物的生物信息学分析
Eur Rev Med Pharmacol Sci. 2015 Nov;19(22):4275-84.
6
Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.主要组织相容性复合体基因在炎症性肠病易感性及疾病表型中的作用
Lancet. 1996 May 4;347(9010):1212-7. doi: 10.1016/s0140-6736(96)90734-5.
7
Systems biology in inflammatory bowel diseases: ready for prime time.炎症性肠病中的系统生物学:准备好进入黄金时代。
Curr Opin Gastroenterol. 2014 Jul;30(4):339-46. doi: 10.1097/MOG.0000000000000081.
8
Genetic determinants associated with early age of diagnosis of IBD.与炎症性肠病早期诊断相关的遗传决定因素。
Dis Colon Rectum. 2015 Mar;58(3):321-7. doi: 10.1097/DCR.0000000000000274.
9
Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: a comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol.炎症基因表达谱在克罗恩病和溃疡性结肠炎中的对比分析:应用逆转录多重连接依赖性探针扩增技术的研究
J Crohns Colitis. 2013 Sep;7(8):622-30. doi: 10.1016/j.crohns.2012.08.015. Epub 2012 Sep 24.
10
MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.微小RNA特征可区分克罗恩病与溃疡性结肠炎。
BMC Immunol. 2015 Feb 10;16:5. doi: 10.1186/s12865-015-0069-0.

引用本文的文献

1
Predictive biomarkers for anti-TNF alpha therapy in IBD patients.炎症性肠病患者抗 TNF-α 治疗的预测生物标志物。
J Transl Med. 2024 Mar 16;22(1):284. doi: 10.1186/s12967-024-05058-1.
2
Enhancing genomic mutation data storage optimization based on the compression of asymmetry of sparsity.基于稀疏性不对称压缩增强基因组突变数据存储优化
Front Genet. 2023 Jun 1;14:1213907. doi: 10.3389/fgene.2023.1213907. eCollection 2023.
3
Harnessing the Power of Precision Medicine and Novel Biomarkers to Treat Crohn's Disease.利用精准医学和新型生物标志物的力量治疗克罗恩病。

本文引用的文献

1
Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine.整合组学以更好地理解炎症性肠病:迈向个体化医学的一步。
J Transl Med. 2019 Dec 13;17(1):419. doi: 10.1186/s12967-019-02174-1.
2
NOD2 Expression in Intestinal Epithelial Cells Protects Toward the Development of Inflammation and Associated Carcinogenesis.肠上皮细胞中 NOD2 的表达可预防炎症的发展和相关的癌变。
Cell Mol Gastroenterol Hepatol. 2019;7(2):357-369. doi: 10.1016/j.jcmgh.2018.10.009. Epub 2018 Oct 23.
3
A new method for evaluating the impacts of semantic similarity measures on the annotation of gene sets.
J Clin Med. 2023 Apr 4;12(7):2696. doi: 10.3390/jcm12072696.
4
Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response.炎症性肠病的治疗方法和治疗反应的预测性生物标志物。
Int J Mol Sci. 2022 Jun 23;23(13):6966. doi: 10.3390/ijms23136966.
一种评估语义相似性度量对基因集注释影响的新方法。
PLoS One. 2018 Nov 27;13(11):e0208037. doi: 10.1371/journal.pone.0208037. eCollection 2018.
4
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.STRING v11:具有增强覆盖范围的蛋白质-蛋白质相互作用网络,支持在全基因组实验数据集的功能发现。
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613. doi: 10.1093/nar/gky1131.
5
Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes.克罗恩病、溃疡性结肠炎和未定型结肠炎的临床表现:症状、肠外表现及疾病表型
Semin Pediatr Surg. 2017 Dec;26(6):349-355. doi: 10.1053/j.sempedsurg.2017.10.003. Epub 2017 Oct 5.
6
Immunopathophysiology of inflammatory bowel disease: how genetics link barrier dysfunction and innate immunity to inflammation.炎症性肠病的免疫病理生理学:遗传学如何将屏障功能障碍和固有免疫与炎症联系起来。
Innate Immun. 2017 Aug;23(6):497-505. doi: 10.1177/1753425917722206.
7
Essential role of small bowel capsule endoscopy in reclassification of colonic inflammatory bowel disease type unclassified.小肠胶囊内镜在未分类的结肠炎症性肠病重新分类中的重要作用。
World J Gastrointest Endosc. 2017 Jan 16;9(1):34-40. doi: 10.4253/wjge.v9.i1.34.
8
NOD2 promotes cell proliferation and inflammatory response by mediating expression of TSLP in human airway smooth muscle cells.NOD2通过介导人气道平滑肌细胞中TSLP的表达促进细胞增殖和炎症反应。
Cell Immunol. 2017 Feb;312:35-41. doi: 10.1016/j.cellimm.2016.11.007. Epub 2016 Nov 17.
9
Endoscopy in the Diagnosis and Management of Complications of Inflammatory Bowel Disease.内镜检查在炎症性肠病并发症的诊断与管理中的应用
Inflamm Bowel Dis. 2016 May;22(5):1184-97. doi: 10.1097/MIB.0000000000000626.
10
The global burden of IBD: from 2015 to 2025.IBD 的全球负担:2015 年至 2025 年。
Nat Rev Gastroenterol Hepatol. 2015 Dec;12(12):720-7. doi: 10.1038/nrgastro.2015.150. Epub 2015 Sep 1.